Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands.
Furue M, Tsuji G.
Int J Environ Res Public Health. 2019 Dec 3;16(23):4864. doi: 10.3390/ijerph16234864.
Chloracne.
Singh S, Manoj R, Gupta A.
JAMA Dermatol. 2024 Jun 1;160(6):668-669. doi: 10.1001/jamadermatol.2024.0928.
Chloracne and chloracnegens.
Tindall JP.
J Am Acad Dermatol. 1985 Oct;13(4):539-58. doi: 10.1016/s0190-9622(85)70196-x.
Chloracne.
Schlessinger DI, Robinson CA, Schlessinger J.
2022 Oct 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Chloracne. Clinical manifestations and etiology.
Zugerman C.
Dermatol Clin. 1990 Jan;8(1):209-13.
Chloracne.
Crow KD.
Br J Dermatol. 1970 Nov;83(5):599-600. doi: 10.1111/j.1365-2133.1970.tb15749.x.
Chloracne. Some recent issues.
Coenraads PJ, Brouwer A, Olie K, Tang N.
Dermatol Clin. 1994 Jul;12(3):569-76.
Chloracne and its potential clinical implications.
Crow KD.
Clin Exp Dermatol. 1981 May;6(3):243-57. doi: 10.1111/j.1365-2230.1981.tb02300.x.
Chloracne, a misnomer and its implications.
Saurat JH, Sorg O.
Dermatology. 2010 Aug;221(1):23-6. doi: 10.1159/000290672. Epub 2010 Apr 30.
Toward elucidation of dioxin-mediated chloracne and Ah receptor functions.
Bock KW.
Biochem Pharmacol. 2016 Jul 15;112:1-5. doi: 10.1016/j.bcp.2016.01.010. Epub 2016 Jan 23.
